We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$510M
AUM Growth
+$54.5M
Cap. Flow
+$16.8M
Cap. Flow %
3.3%
Top 10 Hldgs %
51.22%
Holding
322
New
62
Increased
102
Reduced
99
Closed
50

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.21M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$5.01M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$2.35M
4
UCON icon
First Trust Smith Unconstrained Bond ETF
UCON
+$2.14M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$1.92M

Top Sells

Rank Stock Value
1
KALV
KalVista Pharmaceuticals
KALV
+$1.8M
2
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$850K
3
DFAT icon
Dimensional US Targeted Value ETF
DFAT
+$850K
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$802K
5
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
+$729K

Sector Composition

Rank Sector Weight
1 Technology 11.55%
2 Financials 5.1%
3 Consumer Discretionary 2.98%
4 Communication Services 2.94%
5 Healthcare 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCL icon
251
Carnival Corporation Ltd
CCL
$36.1B
$203K 0.04%
7,227
-3,197
-31% -$68.4K
NBIX icon
252
Neurocrine Biosciences
NBIX
$17.7B
$201K 0.04%
+1,603
New +$184K
IWV icon
253
iShares Russell 3000 ETF
IWV
$19.5B
$201K 0.04%
+573
New +$186K
AMCR icon
254
Amcor
AMCR
$20.6B
$179K 0.04%
+3,899
New +$180K
HBAN icon
255
Huntington Bancshares
HBAN
$35.1B
$173K 0.03%
10,330
-4,575
-31% -$69K
PCG icon
256
PG&E
PCG
$47.8B
$172K 0.03%
12,326
-8,438
-41% -$137K
PATH icon
257
UiPath
PATH
$5.62B
$138K 0.03%
+10,811
New +$130K
ADT icon
258
ADT
ADT
$5.16B
$135K 0.03%
15,983
+4,214
+36% +$34.5K
WEN icon
259
Wendy's
WEN
$1.33B
$122K 0.02%
10,663
+3
+0% +$37
DHT icon
260
DHT Holdings
DHT
$2.97B
$121K 0.02%
11,213
+84
+0.8% +$926
JBLU icon
261
JetBlue
JBLU
$1.96B
$76.1K 0.01%
17,990
+57
+0.3% +$255
AEG icon
262
Aegon
AEG
$13.5B
$73.8K 0.01%
+10,197
New +$68.2K
NMR icon
263
Nomura Holdings
NMR
$28.7B
$73.3K 0.01%
+11,136
New +$65.2K
HAFN icon
264
Hafnia
HAFN
$3.82B
$73K 0.01%
+14,631
New +$71.1K
NWL icon
265
Newell Brands
NWL
$2.16B
$59.5K 0.01%
+11,026
New +$58.4K
TEF
266
DELISTED
Telefonica
TEF
$56K 0.01%
+10,700
New +$53.8K
LYG icon
267
Lloyds Banking Group
LYG
$87.4B
$46.6K 0.01%
10,958
+951
+10% +$3.78K
PLX icon
268
Protalix BioTherapeutics
PLX
$191M
$38.4K 0.01%
25,976
– –
PLUG icon
269
Plug Power
PLUG
$2.92B
$26.9K 0.01%
18,038
+5,000
+38% +$4.99K
LCID icon
270
Lucid Motors
LCID
$2.46B
$21.7K ﹤0.01%
1,031
+9
+0.9% +$215
CHPT icon
271
ChargePoint
CHPT
$133M
$9.27K ﹤0.01%
659
-771
-54% -$10.3K
TLRY icon
272
Tilray
TLRY
$479M
$4.24K ﹤0.01%
+1,022
New +$4.64K
ADP icon
273
Automatic Data Processing
ADP
$100B
– –
-775
Closed -$237K
AEM icon
274
Agnico Eagle Mines
AEM
$72.6B
– –
-3,258
Closed -$353K
ALLE icon
275
Allegion
ALLE
$13B
– –
-1,664
Closed -$217K
9 10
11
12 13

Similar funds

SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Capital Performance Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Capital Performance Advisors held 322 positions worth $510M, up 12% from $456M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Capital Performance Advisors deployed $16.8M of net new capital in Q2 2025, opening 62 new positions and adding to 102 existing holdings. Its largest new stake was Invesco QQQ Trust: 3,857 shares worth $2.13M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $850K trimmed.

  • Capital Performance Advisors's largest Q2 2025 buy was Invesco QQQ Trust: 3,857 shares worth $2.13M.
  • Capital Performance Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $6.21M increase.
  • Capital Performance Advisors's biggest Q2 2025 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $850K.
  • Capital Performance Advisors fully exited KalVista Pharmaceuticals in Q2 2025, selling an estimated $1.8M.
  • Capital Performance Advisors's ten largest holdings make up 51% of its $510M portfolio in Q2 2025.
  • Capital Performance Advisors opened 62 new positions and closed 50 in Q2 2025.
  • Capital Performance Advisors's portfolio value rose 12% quarter-over-quarter to $510M.

Based on Capital Performance Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.